Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 1
1995 1
2000 1
2005 1
2009 1
2010 1
2012 1
2015 2
2016 1
2019 1
2020 3
2021 6
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Malignant Peripheral Nerve Sheath Tumor"
Page 1
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R. Brown R. Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31. Curr Oncol Rep. 2023. PMID: 37906356 Review.
Neurofibromatosis type I (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis represent a diverse group of genetic tumor predisposition syndromes with a shared feature of tumors affecting the peripheral nerve sheaths. PURPOSE OF REVIEW: Many advancement …
Neurofibromatosis type I (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis represent a diverse group of genetic tumor predis …
Systemic Options for Malignant Peripheral Nerve Sheath Tumors.
Hassan A, Pestana RC, Parkes A. Hassan A, et al. Curr Treat Options Oncol. 2021 Feb 27;22(4):33. doi: 10.1007/s11864-021-00830-7. Curr Treat Options Oncol. 2021. PMID: 33641042 Review.
Malignant peripheral nerve sheath tumors (MPNSTs) are rare mesenchymal neoplasms that represent a profound therapeutic challenge due to their high proclivity for recurrence and metastasis and relatively poor response to systemic therapy regimens. While …
Malignant peripheral nerve sheath tumors (MPNSTs) are rare mesenchymal neoplasms that represent a profound thera …
Epithelioid malignant peripheral nerve sheath tumor: clinicopathologic analysis of 63 cases.
Jo VY, Fletcher CD. Jo VY, et al. Am J Surg Pathol. 2015 May;39(5):673-82. doi: 10.1097/PAS.0000000000000379. Am J Surg Pathol. 2015. PMID: 25602794
Epithelioid malignant peripheral nerve sheath tumor (EMPNST) is rare and differs from conventional malignant peripheral nerve sheath tumor by showing diffuse S-100 protein positivity, infrequent association wit …
Epithelioid malignant peripheral nerve sheath tumor (EMPNST) is rare and differs from conventional mal …
Unusual primary tumors of the heart.
Vander Salm TJ. Vander Salm TJ. Semin Thorac Cardiovasc Surg. 2000 Apr;12(2):89-100. doi: 10.1053/ct.2000.5080. Semin Thorac Cardiovasc Surg. 2000. PMID: 10807431 Review.
The benign tumors include rhabdomyomas, fibromas, papillary fibroelastomas, hemangiomas, pericardial cysts, lipomas, hamartomas, teratomas, mesotheliomas, and paragangliomas or pheochromocytomas. The last 3 may also be malignant. The malignant tumors consist of vari …
The benign tumors include rhabdomyomas, fibromas, papillary fibroelastomas, hemangiomas, pericardial cysts, lipomas, hamartomas, teratomas, …
Malignant peripheral nerve sheath tumor: a study of 21 cases.
Chang SM, Ho WL. Chang SM, et al. Zhonghua Yi Xue Za Zhi (Taipei). 1994 Aug;54(2):122-30. Zhonghua Yi Xue Za Zhi (Taipei). 1994. PMID: 7954046
BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is an aggressive tumor of neural origin. ...CONCLUSIONS: Our work revealed that patients with von Recklinghausen's disease, a large unresectable centrally located tumor …
BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is an aggressive tumor of neural origi …
Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
Butler E, Schwettmann B, Geboers S, Hao G, Kim J, Nham K, Sun X, Laetsch TW, Xu L, Williams NS, Skapek SX. Butler E, et al. Pediatr Blood Cancer. 2020 Dec;67(12):e28639. doi: 10.1002/pbc.28639. Epub 2020 Sep 25. Pediatr Blood Cancer. 2020. PMID: 32975370
BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is an aggressive form of soft-tissue sarcoma (STS) in children. ...CONCLUSION: The ability of MEK inhibitors to control MPNST growth cannot simply be predicted by serum drug leve …
BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is an aggressive form of soft-tissue sarcoma …
Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
van Noesel MM, Orbach D, Brennan B, Kelsey A, Zanetti I, de Salvo GL, Gaze MN, Craigie RJ, McHugh K, Francotte N, Collini P, Bisogno G, Casanova M, Ferrari A. van Noesel MM, et al. Pediatr Blood Cancer. 2019 Oct;66(10):e27833. doi: 10.1002/pbc.27833. Epub 2019 Jun 26. Pediatr Blood Cancer. 2019. PMID: 31241238
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNST) are rare tumors of childhood. ...Standard ifosfamide-doxorubicin for unresectable MPNST rendered the best reported outcome. Children with NF1 disease seem to have worse prognosis …
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNST) are rare tumors of childhood. ...Standard ifosfamid …
Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors.
Nishida Y, Urakawa H, Nakayama R, Kobayashi E, Ozaki T, Ae K, Matsumoto Y, Tsuchiya H, Goto T, Hiraga H, Naka N, Takahashi S, Ando Y, Ando M, Kuwatsuka Y, Hamada S, Ueda T, Kawai A. Nishida Y, et al. Int J Cancer. 2021 Jan 1;148(1):140-149. doi: 10.1002/ijc.33201. Epub 2020 Aug 3. Int J Cancer. 2021. PMID: 32638374 Free article. Clinical Trial.
Malignant peripheral nerve sheath tumor (MPNST) often does not respond well to chemotherapy and develops against a background of NF1. ...
Malignant peripheral nerve sheath tumor (MPNST) often does not respond well to chemotherapy and develops …
Primary malignant peripheral nerve sheath tumor of the cauda equina with metastasis to the brain in a child: case report and literature review.
Xu Q, Xing B, Huang X, Wang R, Li Y, Yang Z. Xu Q, et al. Spine J. 2012 Apr;12(4):e7-13. doi: 10.1016/j.spinee.2012.03.030. Epub 2012 Apr 20. Spine J. 2012. PMID: 22521675 Review.
BACKGROUND CONTEXT: Primary intradural malignant peripheral nerve sheath tumors (MPNSTs) are extremely rare; only 23 cases have been reported in the English-language literature till now. ...CONCLUSIONS: Primary intradural MPNST is a very rare entity wi …
BACKGROUND CONTEXT: Primary intradural malignant peripheral nerve sheath tumors (MPNSTs) are extremely rare; onl …
Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, Cecchetto G, Alaggio R, De Sio L, Koscielniak E, Sotti G, Treuner J. Carli M, et al. J Clin Oncol. 2005 Nov 20;23(33):8422-30. doi: 10.1200/JCO.2005.01.4886. J Clin Oncol. 2005. PMID: 16293873 Clinical Trial.
PURPOSE: To assess the value of chemotherapy and radiotherapy in children with malignant peripheral nerve sheath tumors (MPNSTs) and to identify risk factors associated with outcome. ...Postoperative radiotherapy may have a role in improving local cont …
PURPOSE: To assess the value of chemotherapy and radiotherapy in children with malignant peripheral nerve sheath …
21 results